跳转至内容
Merck
CN

AB9704

Sigma-Aldrich

Anti-LRRK2 Antibody

serum, Chemicon®

别名:

Dardarin, Leucine-rich repeat kinase 2

登录查看公司和协议定价

选择尺寸


关于此项目

UNSPSC代码:
12352203
eCl@ss:
32160702
NACRES:
NA.41
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

生物来源

sheep

质量水平

偶联物

unconjugated

抗体形式

serum

抗体产品类型

primary antibodies

克隆

polyclonal

种属反应性

human

制造商/商品名称

Chemicon®

技术

immunohistochemistry: suitable

同位素/亚型

IgG

NCBI登记号

UniProt登记号

运输

dry ice

靶向翻译后修饰

unmodified

基因信息

human ... LRRK2(120892)

免疫原

Synthetic peptide from human LRRK2.

应用

Detect LRRK2 using this ANTI-LRRK2 Antibody validated for use in IH.
Immunohistochemistry: 1:1,000-1:8,000. The antibody works well on both cryosections and paraffin embedded tissues.

Optimal working dilutions must be determined by the end user.
Research Category
Neuroscience
Research Sub Category
Neurodegenerative Diseases

生化/生理作用

Recognizes LRRK2 (leucine-rich repeat kinase 2, Dardarin)

外形

Sheep serum. Lyophilized. Reconstitute with 100 μL of sterile distilled water.

制备说明

Maintain lyophilized material at -20°C to -70°C for up to 12 months after date of receipt. After reconstitution maintain at -20°C to -70°C in undiluted aliquots for up to 6 months. Avoid repeated freeze/thaw cycles. Glycerol (ACS grade or better) can be added (1:1) for additional stability.

法律信息

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

免责声明

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

未找到合适的产品?  

试试我们的产品选型工具.

储存分类代码

11 - Combustible Solids

WGK

WGK 1

闪点(°F)

Not applicable

闪点(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Saskia Biskup et al.
BMC neuroscience, 8, 102-102 (2007-11-30)
Mutations within the leucine-rich repeat kinase 2 (LRRK2) gene account for a significant proportion of autosomal-dominant and some late-onset sporadic Parkinson's disease. Elucidation of LRRK2 protein function in health and disease provides an opportunity for deciphering molecular pathways important in

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持